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Aims: We have investigated the effect of surface charge of model lipid membranes on their interactions with
dendriplexes formed by HIV-derived peptides and 2 types of positively charged carbosilane dendrimers (CBD).
Methods: Interaction of dendriplexes with lipid membranes was measured by ﬂuorescence anisotropy, dynamic
light scattering and Langmuir–Blodgett techniques. The morphology of the complexes was examined by trans-
mission electron microscopy.
Results: All dendriplexes independent of the type of peptide interacted with model lipid membranes. Negatively
charged vesicles composed of a mixture of DMPC/DPPG interacted more strongly, and it was accompanied by an
increase in anisotropy of the ﬂuorescent probe localized in polar domain of lipid bilayers. There was also an
increase in surface pressure of the lipid monolayers. Mixing negatively charged liposomes with dendriplexes in-
creased liposome size and made their surface charges more positive.
Conclusions:HIV-peptide/dendrimer complexes interactwithmodel lipidmembranes depending on their surface
charge. Carbosilane dendrimers can be useful as non-viral carriers for delivering HIV-peptides into cells.© 2015 Elsevier B.V. All rights reserved.1. Introduction
Human immunodeﬁciency virus (HIV) is a retrovirus responsible for
the acquired immunodeﬁciency syndrome (AIDS) [1,2]. Antiretroviral
therapy (ART) can greatly improve quality of life and decrease viral
load, but several limitations of current approaches must be addressed
to give safe and effective therapy [3]. The focus must now be on the
development of new preventive and therapeutic vaccines, and their
effective delivery into the target cells. The application of dendritic cells
(DCs) as a vaccine adjuvant is one way to improve deterioration of im-
mune functioning in HIV-1-infected individuals [4,5]. For therapeutic
purposes, the antigen (HIV-derived peptide) should be transported
through the cell membrane into the cytoplasm. A method to load DCsnic carbosilane dendrimer; DC,
1,2-dimyristoyl-sn-glycero-3-
HIV, human immunodeﬁciency
ysis light scattering; PB, phos-
iophysics, University of Lodz,
354144; fax: +48 426354474.with antigens is therefore urgently needed, since it requires an efﬁcient
carrier to deliver antigen across the plasma membrane. Different
methods have so far included the use of liposomes, nanoparticles, poly-
meric micelles and nanogels [6–13]. In this context, dendrimers offer an
alternative approach [14,15].
Dendrimers are hyperbranched, multifunctional and completely de-
ﬁned macromolecules that are already known to have high therapeutic
potential in delivering biomolecules [5,6,15]. Among various types of
cationic dendrimers of different generation, the carbosilane dendrimers
(CBD) of second generation are of special interest. These dendrimers
show good toxicity proﬁle up to concentration of 5 μMand antibacterial
properties [16]. CBDs were primarily synthesized for delivery of siRNA
and other oligonucleotides. The negatively charged siRNA can interact
electrostatically with cationic dendrimers so the stable complexes are
formed. In addition, due to certain neutralization of the siRNA negative
charge this complex can strongly interact with negatively charged cell
surface in contrast with naked siRNA, that is repulsed from the cell sur-
face. In our recentworkswe studied themechanisms of interactionwith
model lipid membranes (liposomes and monolayers) of two types of
CBDs containing 16 amino groups at the surface, but differing in the
composition of their branched core: ﬁrst one, BDBR0011, contained
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silicon bonds (CBD-OS). While CBD-CS are stable in aqueous solution
CBD-OS are slowly hydrolyzed.
The study of the interaction of dendriplexes based on CBDs and
HIV-1 derived peptides has not been reported so far. In this work
we therefore studied the interaction of dendriplexes based on CBDs
and three different peptides that are prospective for development
of artiﬁcial immune system against HIV-1: P24, Gp160 and Nef.
We explored the nature and mechanism of interaction of the HIV-
peptide/dendrimer complex with artiﬁcial lipid membranes com-
posed of zwitterionic or negatively charged phospholipids [18–20].
We showed, that these complexes interact with DMPC and DMPC/
DPPG membranes most probably by being incorporated into their
polar domains. The presence of dendriplexes markedly changed
some parameters of the DMPC/DPPG lipid membranes in comparison
with DMPC membranes. In contrast with dendriplexes, we have
shown that non-complexed peptides did not interact with lipid
membranes. The results indicate the importance of electrostatic in-
teractions between dendriplexes and lipid membranes. The analysis
of the interaction of dendriplexes with model membranes can help
develop the strategy for immunotherapy of HIV-1 infection using
DCs loaded with synthetic HIV-derived peptides, which can be deliv-
ered by CBD dendrimers.
2. Materials and methods
2.1. Dendrimers
Second generation of cationic carbosilane dendrimers with car-
bon silicon bonds BDBR0011 (CBD-CS) and oxygen silicon bonds
NN16 (CBD-OS) has been used. Both CBDs contain 16 cationic sur-
face terminal groups and have following composition: CBD-CS,
C128H316I16N16O8Si13, Mw = 4603.6 g/mol; CBD-OS, C144H348I16N16Si13,
Mw = 4699.99 g/mol. Dendrimers were synthesized in the
Departamento de Quimica Inorganica, Universidad de Alca, Spain
[21–24], the structures of CBDs being shown in Fig. 1.Fig. 1.Molecular structure of the carbosilane dendrimers of 2nd generation. W2.2. HIV-derived peptides
HIV-derived peptides were prepared by Eurogentec (Belgium)
- Peptide derived from Nef sequence, HIV-HXB2 location Nef
(172–191): NHGMDDPEREV-LEWRFDSRLAFCOOH, length 20
amino-acids, charge (−3);
- Peptide derived from Gag-P24 sequence, HIV-HXB2 location P24
(71e80): NH-DTINEEAAEW-COOH, length 10 amino-acids, charge
(−4);
- Peptide derived from envelope Gp160 sequence, HIVHXB2 location
Gp160 (634e648): NH-EIDNYTNTIYTLLEE-COOH, length 15 amino-
acids, charge (−4)
2.3. Phospholipids
DMPC-1,2-dimyristoyl-sn-glycero-3-phosphocholine and DPPG-
dipalmitoylphosphatidylglycerol were synthesized by Avanti Polar
Lipids Inc. (USA). Other reagents were purchased from Sigma-Aldrich
Company (USA).
2.4. Preparation of dendriplexes
Dendriplexes were formed by adding dendrimers into peptide
solutions at a molar ratio of 1:3 (peptide:dendrimer). CBD dendrimers
and HIV-derived peptides were dissolved in 10mMNa-phosphate buff-
er at pH 7.4. The mixture was vortexed and incubated for 10 min at
room temperature (approx. 20 °C).
2.5. Preparation of liposomes
To prepare the liposomes, the DMPC or DMPC/DPPG mixtures
(9:1 w/w) were dissolved in chloroform and placed into a round
glass ﬂask under vacuum to evaporate the solvent. The dry lipid ﬁlm
was hydrated with buffer to yield a lipid concentration of 0.3 mg/ml,ith Si\C bonds—CBD-CS (BDBR0011); with Si\O bonds—CBD-OS (NN16).
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times through Millipore polycarbonate ﬁlters (100 nm pore size) using
Avanti extruder (Avanti Polar Lipids, USA) to get large unilamellar ves-
icles (LUVs). The temperature of samples during extrusion was kept at
approx. 37 °C, which is well above the main phase-transition tempera-
ture of the lipids (~24 °C).
2.6. Measurement of particle size
The hydrodynamic diameter of vesicles wasmeasured using a dy-
namic light-scattering technique using Zetasizer Nano-ZS (Malvern
Instruments, UK). Samples were placed in plastic Malvern cells
(DTS0012) in 10 mM Na-phosphate buffer at pH 7.4 (ﬁltered twice
through 0.22 μm ﬁlters). The refraction factor was assumed to be
1.33 at a detection angle of 90°, a wavelength of 633 nm, and the
sample temperature during measurements was 25 °C [25,26]. Particle
size was measured from the average of 11–15 cycles. Malvern software
was used to analyze the data.
2.7. Measurement of zeta potential
The electrophoretic mobility of the samples in an applied electric
ﬁeld was measured in Malvern capillary plastic cells (DTS1061) using
Zetasizer Nano-ZS. The zeta potential was calculated directly from the
Helmholtz–Smoluchowski equation with the Malvern software [27,
28]. HIV-derived peptides alone or complexed with CBD dendrimers
were added to 1 ml liposome suspension to obtain dendriplex/lipid
molar ratios of 1:300, 1:150, 1:100, 1:50, 1:30, 1:15, 1:10, 1:7.5, and
1:5. Samples were prepared in 10 mM Na-phosphate buffer at pH 7.4
(ﬁltered twice through 0.22 μm ﬁlters), and measured at 25 °C. Zeta
potentials were averaged from 11 to 13 measurements.
2.8. Fluorescence spectroscopy
Fluorescence anisotropy was measured with a Perkin-Elmer (U.K.)
LS-50B spectroﬂuorimeter. Two ﬂuorescent probes were used to
monitor membrane ﬂuidity. l,6-Diphenyl-l,3,5-hexatriene (DPH)
was located in the hydrophobic region of the lipid membrane,
while 1-(4-(trimethylamino)phenyl)-6-phenylhexa-1,3,5-triene
(TMA-DPH) probes were near the hydrophilic part of the lipid bilayer.
The molar ratio of phospholipid to probe was 300:1. Excitation at
348 nm and emission at 426 nm wavelengths were used to analyze the
probe mobility in the bilayer [29,30]. For both probes the slits widths
used were 5 nm and 3 nm for excitation and emission monochromators,
respectively. The measurements were performed at 37 °C, i.e. well above
the main phase-transition temperature of lipids. Steady-state ﬂuores-
cence anisotropy values (r) were calculated using Perkin-Elmer software
from Jablonski's equation:
r ¼ IVV−GIVHð Þ= IVV þ 2GIVHð Þ
where IVV and IVH are the vertical and horizontal ﬂuorescence intensities,
respectively, to the vertical polarization of the excitation light beam.
G = IHV/IHH (grating correction factor) corrects the polarizing effects
of the monochromator.
2.9. Monolayer technique
A Langmuir–Blodgett method was applied for monolayer experi-
ments. A small Teﬂon cell of circular shape (volume 4.5 ml) was used.
Appropriate amounts of lipid dissolved in chloroform at 0.3 mg/ml
were added to the surface of 10 mM Na-phosphate buffer at pH 7.4, to
reach a surface pressure close to 30 mN/m that corresponds to the con-
densed state of the monolayer. Wilhelmy method has been used to
measure surface pressure by means of PS4 sensor (NIMA Technology,
UK) [31]. When surface pressure reached 30 mN/m and stabilized,peptides or peptide/dendrimer complexes were added to the water
subphase (under themonolayer) through a special channel in a concen-
tration of 0.25 μM, and the surface pressure was registered until steady-
state value was reached.
2.10. Transmission electron microscopy
The effect of peptide/dendrimer complexes on the morphology of
liposomes was examined by transmission electron microscopy
(TEM; JEOL-10, JEOL Ltd., Tokyo, Japan). Dendriplexes were added
to liposomes suspended in 10 mM Na-phosphate buffer at pH 7.4 with
a molar ratio of 1:25 (dendriplex to lipid). The resultant complexes
were placed on a carbon surface of a 200-mesh copper grid (Ted Pella,
Inc., USA) 10 min and drained with blotting paper. Samples were nega-
tively stained with 2% (w/v) uranyl acetate (Sigma) for 2 min. Amagniﬁ-
cation of 50,000–100,000× proved best for examining liposomes
interacting with LUVs with peptide/dendrimer complexes.
2.11. Statistical analysis
Origin 8 software (Microcal Software Inc., Northampton, MA, USA)
was used for exponential curve-ﬁtting and statistical analysis. Data
were obtained from a minimum 3 independent experiments and pre-
sented as mean ± SD (standard deviation).
3. Results and discussion
3.1. Fluorescence anisotropy
Liposomes of different lipid composition, DMPC and DMPC/DPPG
(9:1 w/w) were used in order to model the interactions between HIV-
peptide/dendrimer complexes (dendriplexes) with cell membrane.
The 1,2-dimyristoyl-sn-glycero-3-phosphatidylcholine (DMPC) was
chosen as synthetic analog of lecithin, the main component of lipid
membrane matrix of living cells. The dipalmitoylphosphatidylglycerol
(DPPG) was used to prepare negatively charged membrane which can
simulate the charge of living cell. However, due to the presence of pro-
teins in the cell membrane and the afﬁnity of dendrimers to proteins
[16,22,24] the interaction of dendriplexes with biological membranes
will be more complex than with the model membranes. The effect of
dendriplexes on model lipid bilayers was measured by ﬂuorescence
anisotropy using DPH and TMA-DPH ﬂuorescent probes. This gave
data on membrane ﬂuidity that reﬂected the effect of the proteins or
dendriplexes on the order of the lipids in the bilayer's hydrophobic
and polar part, respectively. The DPH probe has cylindrical symmetry
around its long axis in the lipid bilayer [32], and is aligned with the
axis parallel to the acyl chains of the lipid [33].
The TMA-DPH probe is located in the head group region of the
lipid membrane [34]. Fig. 2 shows the effect of peptides or peptide/
dendrimer complexes on the ﬂuorescence anisotropy of liposomes
formed with DMPC or DMPC/DPPG (9:1w/w) phospholipids labelled
with TMA-DPH (A) or DPH (B) probes. An increased concentration of
dendriplexes signiﬁcantly increased TMA-DPH anisotropy for nega-
tively charged liposomes (DMPC/DPPG). The effect was stronger for
CBD-CS based dendriplexes in comparison with CBD-OS. However,
the ﬂuorescent anisotropy of zwiterionic DMPC liposomes was not
signiﬁcantly changed by dendriplexes. The naked peptides did not
affect membrane ﬂuorescence anisotropy either for neutral or nega-
tively charged liposomes. Increase in anisotropy in the presence of
dendriplexes was attributed to a decrease in membrane ﬂuidity,
which may be due to some chelation as a result of interaction of posi-
tively charged dendriplexes with negatively charged membranes.
Negatively charged peptides are repulsed from the negatively charged
surface of DMPC–DMPG liposomes, orweakly interact with zwitterionic
DMPC liposomes; thus they do not affect the TMA-DPH ﬂuorescence
anisotropy (Fig. 2A).
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isotropy is not uniform. There was a small decrease in anisotropy
for both DMPC and DMPC–DPPG liposomes for some peptides, as
well as a decrease of ﬂuorescence anisotropy for dendriplexes com-
posed of CBD-CS dendrimers for negatively charged lipids. Little or no
increase of anisotropy was seen with zwitterionic DMPC liposomes.
The data suggest a weaker effect of dendriplexes on the hydrophobic
domain of the membrane (Fig. 2B).
3.2. Zeta potential and size of liposome/dendriplex systems
To correlate the interaction between dendriplexes and vesicles of
different lipid composition observed using ﬂuorescence anisotropy,
DLS and zeta potential experiments were conducted. Zeta potential
measurements are important to control the electrical charge properties
of nanoparticles. Analyzing the electrical charge characteristics allows
better understanding the interactions between dendriplexes and lipo-
somes and therefore determining the charge behavior of the samples.
The changes in zeta size (hydrodynamic diameter) of liposomes at
their interaction with peptides or peptide/dendrimer complexes
are given in Fig. 3. The hydrodynamic diameters of the DMPC or
DMPC/DPPG liposomes in controls were 111 ± 1.7 and 104 ± 1.6 nm,Fig. 2. Fluorescent anisotropy of TMA-DPH or DPH probes in liposomal membranes contain
(A)—TMA-DPH ﬂuorescence anisotropy estimatesmembrane ﬂuidity in themembrane interfac
bic interior region of the membrane.respectively, in a good agreement with the diameter of polycarbonate
ﬁlter pores used for liposome preparation as well as with our previous
studies [17]. With increased concentration of peptides, the size of both
types of LUVs was practically unchanged (Fig. 3A), but the size of
liposomes in the presence of dendriplexes signiﬁcantly increased,
especially with dendriplexes containing CBD-OS dendrimers. The
hydrodynamic diameter of DMPC liposomes in the presence of the
highest CBD-OS dendriplex/lipid molar ratio (0.2:1) increased to
190 ± 17.5 nm (P24), 153 ± 17 nm (Nef) and 165.5 ± 11.8 nm
(GP160). For DMPC/DPPG liposomes, the hydrodynamic diameter in-
creased to 235 ± 13 nm (P24), 217 ± 27 nm (Nef) and 199 ± 10.3 nm
(GP160) at the same molar ratio (Fig. 3C).
For dendriplexes composed of CBD-CS dendrimers, the difference
between liposome size with or without dendriplexes was less obvious;
DMPC liposomes size increased to 124 ± 2.6 nm (P24), 127 ± 3.0 nm
(Nef) and 129.9±5.5 nm(GP160). For DMPC/DPPG liposomes, the par-
ticle sizes changed to 137 ± 3.6 nm (P24), 145.6 ± 9 nm (Nef) and
140.8 ± 4 nm (GP160) (Fig. 3B).
It is likely that in the case of naked peptides, the negatively charged
thin layer is formed at the liposome surface, which does not contribute
signiﬁcantly to the particle diameter. In contrast, dendriplexes can
induce aggregation of vesicles. This effect is more pronounced foring DMPC or DMPC/DPPG (9:1)w/w phospholipids. Molar ratio of probe to lipid=1:300.
e region; (B)—DPH ﬂuorescence anisotropy estimatesmembrane ﬂuidity in the hydropho-
Fig. 2 (continued).
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molar ratio was 1:3, the dendriplexes are positively charged. There-
fore they will strongly interact with negatively charged liposomes
and will induce their aggregation.
Interactions between liposomes and peptides or dendriplexes were
also characterized by measurements of zeta potential. Addition of pep-
tides alone to a suspension of DMPC liposomes decreased the zeta po-
tential of LUVs from−5.73 ± 1.3 mV to−20 ± 3 mV (P24),−29 ±
5 mV (Nef) and−25 ± 6 mV (GP160), whereas the zeta potential of
DMPC/DPPG liposomes was unaltered in the presence of peptides
(Fig. 4A). Addition of dendriplexes to a liposome suspension had the
opposite effect.
All tested dendriplexes changed the zeta potential from negative to
positive values. After addition of dendriplexes containing the CBD-CS
dendrimer at a dendriplex/lipid molar ratio 0.1:1, the zeta potential of
liposomes composed of DMPC increased from −3.6 ± 1.84 mV to
16.7 ± 1.5 mV (P24), 16 ± 1.1 mV (Nef) and 17 ± 1.6 mV (GP160)
(Fig. 4B). Peptide/dendrimer complexes formed with the CBD-OS den-
drimer changed the liposome surface charge from−4.07 ± 0.74 mV
to 21 ± 0.9 mV (P24), 21.2 ± 2 mV (Nef) and 22.7 ± 1.5 mV (GP160)
(Fig. 4C). For LUVs prepared using DMPC/DPPG, the difference be-
tween surface charge of control liposomes and liposomes treated
by dendriplexes was more pronounced than for DMPC LUVs.
The presence of CBD-CS dendriplexes increased the zeta potential of
DMPC/DPPG liposomes from−31.4± 1.07mV to 20.2± 1.7mV (P24),21±1.6mV (Nef) and 22±1mV (GP160) (Fig. 4B). Addition of CBD-OS
dendriplexes changed particle surface potential from−30.7± 1.0mV to
26.6 ± 1.2 mV for P24, 27 ± 1.4 mV for Nef and 29 ± 1.7 mV for GP160
(Fig. 4C).
Summarizing the results in Figs. 3 and 4, we can conclude that all the
HIV-derived peptides (not complexed with dendrimers) had no effect
on the size of DMPC liposomes, whereas the zeta potential decreased.
The decrease of zeta potential is a proof of adsorption of peptides to a li-
posome surface. However, as we mentioned above the peptide shell is
too thin to affect the liposome size. For DMPC/DPPG liposomes, peptides
aloneproduced no signiﬁcant changes in theparametersmeasured. This
result is obvious and is connected with repulsion of the peptides from
negatively charged surface of liposomes. In contrast with the effect of
peptides, adding peptide/dendrimer complexes shifted the zeta poten-
tial of DMPC and DMPC/DPPG liposomes towards positive values, as an-
ticipated considering the positive surface charge of the dendriplexes.
The hydrodynamic diameter of negatively charged DMPC/DPPG lipo-
somes signiﬁcantly increased in the presence of dendriplexes contain-
ing both dendrimers, which suggests formation of larger aggregates of
liposome–dendriplexes due to strong adsorption of positively charged
dendriplexes onto negatively charged liposome surfaces. We previ-
ously showed [7] that the presence of non-complexed carbosilane
dendrimers in a suspension of LUVs composed of DMPC did not sig-
niﬁcantly change vesicle size, but vesicles formed by DMPC/DPPG
had a more pronounced difference. For vesicles prepared from pure
Fig. 3. Average zeta size of DMPC (left panels) and DMPC/DPPG (9:1), w/w (right panels) LUVs exposed to HIV-derived peptides (A) and their complexes with carbosilane dendrimers,
CBD-CS (B); CBD-OS (C).
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both the carbosilane dendrimers examined interacted mostly with
negatively charged components of the lipid membrane, reﬂecting the
importance of lipid composition in membrane-dendrimer interactions
[7]. However, interactions between LUVs and peptides complexed
with CBD-OS had similar character to those of CBD-CS. CBD-OS caused
more pronounced changes in the measured parameters for both the
DMPC and DMPC/DPPG lipid vesicles.
It is interesting to compare the effect of dendriplexes composed
either of peptides or siRNA on the zeta potential. As we mentioned
above, the dendriplexes composed of siRNA and CBD-CS resulted in
the decrease of zeta potential, but those based on CBD-OS resulted in
its increase tomore positive values. This has been attributed to different
rearrangements of siRNA at the liposome surface (see Ionov et al. 2012).
In contrast with siRNA-based dendriplexes those composed of HIV-1
derived peptides uniformly increase zeta potential independently on
the dendrimer structure. We can speculate that peptides more strongly
interact with dendrimers due to their negative charge and, additionally,
neutral amino acids can partially penetrate into dendrimer core. Thus,
the peptide-based dendriplexes represent more compact particles that
do not allow substantial rearrangements of the peptides and dendrimers
after interaction with vesicles.
3.3. Monolayer measurements
To explore themechanisms of interactions between lipidmembrane
and HIV-peptide/dendrimer complexes, the monolayer technique wasused. The popular approach to describe a monolayer system is to ana-
lyze its surface pressure–area isotherm [35]. Monolayer compression
leads to changes in the lipid packing, which can bemeasured by the sur-
face pressure of the ﬁlm [36]. We prepared monolayers composed of a
DMPC or DMPC/DPPG mixture (9:1) w/w at the air-water interface.
Na-phosphate buffer (10 mM, pH 7.4) was used as a subphase. The sur-
face pressure ofmonolayers was set at 30mN/m to correspondwith the
condensed state of the membrane.
Changes in surface pressure with or without peptides/peptide com-
plexes and dendrimers are shown in Fig. 5. A signiﬁcant increase in sur-
face pressure occurred in all cases of lipid formulations treated with
dendriplexes, but not with peptides. Dendriplexes formed using CBD-
OS dendrimers induced more visible changes in surface pressure than
dendriplexes with CBD-CS dendrimers (Fig. 5). Dendriplexes with CBD-
OS interacted more strongly with uncharged than negative monolayers.
These results indicate that analyzed dendriplexes interact with DMPC
and DMPC/DPPG lipid monolayers. Most probably the dendriplexes be-
come incorporated into the polar domain of the monolayer and caused
its additional condensation, which is themain reason for an increase sur-
face pressure. This is supported by data from ﬂuorescence anisotropy.
Uncomplexed peptides interacted weakly with lipid monolayers, which
agreeswith theweak ﬂuidity changes in the ﬂuorescencemeasurements.
3.4. The morphology of liposome–dendriplex complexes studied by TEM
The effect of dendriplexes on liposome morphology was examined
by TEM. Due to similarities in the peptides and dendriplexes used, we
Fig. 5. Changes of surface pressure of monolayers formed by DMPC and DMPC/DPPG lipid
systems in the presence of peptides or peptide/dendrimer complexes at 0.25 μM in the
water subphase.
Fig. 4. Zeta potential of DMPC (left panels) andDMPC/DPPG (right panels) LUVs exposed toHIV-derived peptides (A) and its complexeswith carbosilane dendrimers, CBD-CS (B); CBD-OS (C).
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study of the morphology of dendriplexes and their complexes with
lipid vesicles. The structures of complexed (lower panel) and non-
complexed (upper panel) lipid vesicles shown in Fig. 6 indicate the
ability of dendriplexes to interact with lipid membranes.
In all cases the size of liposomes varied from 100 to 160 nm,
conﬁrming the correctness of vesicles isolation. DMPC and DMPC/
DPPG liposomes incubated with peptide/dendrimer complexes re-
vealed large structural variations that were of different shape and
morphology compared with untreated liposomes, which suggests
that dendriplexes interact with both types of liposome formulation.
In the case of DMPC/DPPG liposomes, all dendriplexes were com-
plexed with LUVs, whereas the liposomes composed of DMPC and
the peptide/dendrimer complexes not attached to LUVs can clearly be
seen (Fig. 6). These ﬁndings conﬁrm the results obtained by ﬂuores-
cence and zeta techniques, and add further evidence for the stronger in-
teraction of dendriplexeswith the negatively charged lipidmembranes,
which can be explained by the electrostatic nature of interaction be-
tween dendriplexes and lipid membrane.
By means of steady-state ﬂuorescence anisotropy method we
showed that interaction of both CBDs with neutral and negatively
charged phospholipids resulted in an increase of ﬂuorescence anisotro-
py of the probes localized in hydrophobic and polar parts of the bilayer.
This has been explained by dendrimer-induced ordering of the lipid
bilayer. However, CBD-CS interacted more strongly with hydropho-
bic part and weaker with hydrophilic part of bilayers, while opposite
tendency was observed for CBD-OS dendrimers. Both dendrimers
interacted more strongly with negatively charged liposomes in
Fig. 6. Electronmicrographs of DMPC or DMPC/DPPG lipid vesicles (upper panel) and theirmixturewith peptide/dendrimer complex [p24/CBD-CS] peptide/lipid ratio 0.02 (lower panel).
Dendriplexes were formed in 10 mMNa-phosphate buffer at pH 7.4 and immediately mixed with liposome suspensions. Magniﬁcation 100,000×; bar = 200 nm. To obtain greater con-
trast, the color of the microphotographs has been reversed.
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periments on lipid monolayers. CBD-OS dendrimers increased more
strongly surface pressure of monolayers in comparison with CBD-
CS. It has been suggested that cationic CBD can penetrate into lipid
monolayers or create ordered domains at the surface of lipid layer.
The possibility of penetration of CBD-CS inside the bilayer has been
supported also by NMR data, which revealed interaction of CBD-CS
with acyl chains of phospholipids. It has been suggested that dendri-
mer core can also be involved in these interactions. The mechanisms
of CBD–membrane interactions are, however, not fully understood
yet [17]. Further, we studied also interaction of CBD modiﬁed by
siRNA with unilamellar vesicles composed of DMPC or a mixture of
DMPC and DPPG as well as DPPG alone. Similarly to naked CBD those
modiﬁed by siRNA interacted more strongly with negatively charged
vesicles. This interaction has been accompanied by increase of average
size of vesicles, which indicate formation of larger aggregates. Themea-
surement of zeta potential, however, showed different effect of CBD-CS
and CBD-OS on the vesicle properties. While CBD-CS–siRNA complexes
resulted in a decrease of zeta potential to more negative values,
the complexes based on CBD-OS exhibited an increase of zeta potential
to more positive values [7]. A possible explanation of this effect is
due to different localization of dendrimers in lipid bilayers. CBD-CS
dendrimers are incorporated more deeply into lipid bilayer interior,
while CBD-OS preferably interact with polar part of the membrane.
This results in different localization of siRNA (see Ionov et al. 2012 for
detailed explanation). The obtained results indicate that CBD has great
potential for siRNA delivery. In analogy with above mentioned studies,
we propose that CBD can be effective carriers also for delivery of select-
ed HIV-1 peptides to DCs.
According to Scopus database, ourwork is theﬁrst study of the inter-
action of carbosilane dendrimer–short peptide complexes with model
lipid membranes. Recently there was, however, attempt to use molecu-
lar dynamic simulation method to study the mechanisms of interaction
of the dendrimer-short peptide complexes with lipid membranes. The
peptide consisted of three histidines (H)with the pH-sensitive property
and an arginine (R). It has been shown that dendrimers are adsorbed or
penetrate through the negatively charged, asymmetrical bilayer de-
pending on the pH environment [37]. These model studies should be
considered as an additional approvement of the strategy indicated inthis work on the high perspective of peptide based dendriplexes as pos-
sible carriers of nanostructured vaccines.
4. Conclusions
We have demonstrated that HIV–peptides complexed with
carbosilane dendrimers interact with model lipid membrane. The
results give an example of the importance of electrostatic interac-
tions between peptide/polymer complexes and lipid systems. The
strong interaction of dendriplexes with negatively charged lipid
membranes is due to electrostatic interaction of positively charged
dendriplexes and negatively charged lipids, whereas interaction of
dendriplexes with vesicles composed of zwitterionic lipids is due
to disturbances in the hydrophobic domain of the membrane. The
results obtained suggest that the carbosilane dendrimers studied
can be considered as carriers for delivering HIV-peptides to target
cells.
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